TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 156 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $312,857,000 | +197.8% | 4,157,552 | +6.2% | 0.01% | +350.0% |
Q1 2022 | $105,067,000 | -43.2% | 3,913,128 | +0.9% | 0.00% | -50.0% |
Q4 2021 | $184,949,000 | -28.0% | 3,877,339 | +0.3% | 0.00% | -33.3% |
Q3 2021 | $256,908,000 | -11.0% | 3,867,337 | +4.5% | 0.01% | -14.3% |
Q2 2021 | $288,797,000 | -17.3% | 3,701,567 | +0.2% | 0.01% | -22.2% |
Q1 2021 | $349,278,000 | -16.7% | 3,692,540 | +7.3% | 0.01% | -25.0% |
Q4 2020 | $419,221,000 | +66.8% | 3,440,460 | +19.6% | 0.01% | +50.0% |
Q3 2020 | $251,375,000 | +39.8% | 2,877,460 | +3.4% | 0.01% | +33.3% |
Q2 2020 | $179,765,000 | +92.8% | 2,783,183 | +33.3% | 0.01% | +50.0% |
Q1 2020 | $93,256,000 | -23.8% | 2,088,121 | +6.3% | 0.00% | 0.0% |
Q4 2019 | $122,414,000 | +350.6% | 1,965,234 | +172.0% | 0.00% | +300.0% |
Q3 2019 | $27,169,000 | +53.4% | 722,566 | +66.0% | 0.00% | 0.0% |
Q2 2019 | $17,712,000 | – | 435,180 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,737,297 | $176,802,000 | 6.75% |
MPM BioImpact LLC | 308,686 | $19,938,000 | 5.30% |
Burrage Capital Management LLC | 77,172 | $4,985,000 | 3.49% |
Orbimed Advisors | 2,745,327 | $177,321,000 | 2.50% |
Parkman Healthcare Partners LLC | 110,318 | $7,125,000 | 2.01% |
SECTORAL ASSET MANAGEMENT INC | 284,486 | $18,375,000 | 1.69% |
First Light Asset Management, LLC | 192,829 | $12,455,000 | 1.45% |
Asymmetry Capital Management, L.P. | 22,608 | $1,460,000 | 1.12% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,236,000 | 0.74% |
Prosight Management, LP | 25,602 | $1,654,000 | 0.71% |